Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia.

Guray Saydam Ali Unal İbrahim Celallettin Haznedaroğlu Abdullah Hacıhanefioğlu Özgür Mehta Erdal Kurtoğlu Mesut Gocer Mehmet Turgut Engin Kelkitli Memis Hilmi Atay Nil Guler Basak Unver Koluman Mehmet Sonmez Nergiz Erkut Emin Kaya İrfan Kuku Mehmet Ali Erkurt Gülsüm Özet Funda Ceran Fahri Şahin Nur Akad Soyer Meliha Nalçacı Mehmet Yılmaz Sirac Bozkurt Birkan Aver Begum Ozdengulsun Egemen Ozbilgili Osman Ilhan

Published in: International journal of hematologic oncology (2022)

The response rates of CP-CML patients to the tyrosine kinase inhibitors were satisfactory. In addition to tolerability and side effect profiles of drugs, comorbidity status of patients should also be considered in treatment choice in CML patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic myeloid leukemia
chronic kidney disease
prognostic factors
peritoneal dialysis
clinical trial
machine learning
deep learning
big data
patient reported
combination therapy